Amgen Inc.
AMGN
$316.57
$4.381.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.03B | 31.14B | 29.54B | 28.18B | 26.91B |
| Total Other Revenue | 1.40B | 1.39B | 1.39B | 1.35B | 1.28B |
| Total Revenue | 33.42B | 32.53B | 30.93B | 29.53B | 28.19B |
| Cost of Revenue | 10.46B | 12.20B | 10.70B | 9.28B | 7.80B |
| Gross Profit | 22.97B | 20.33B | 20.24B | 20.26B | 20.40B |
| SG&A Expenses | 7.10B | 7.49B | 7.22B | 6.73B | 6.18B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 230.00M | 170.00M | 897.00M | 1.00B | 901.00M |
| Total Operating Expenses | 23.75B | 25.64B | 24.22B | 22.08B | 19.66B |
| Operating Income | 9.68B | 6.90B | 6.72B | 7.46B | 8.53B |
| Income Before Tax | 4.61B | 4.68B | 3.53B | 4.35B | 7.86B |
| Income Tax Expenses | 519.00M | 449.00M | 395.00M | 582.00M | 1.14B |
| Earnings from Continuing Operations | 4.09K | 4.23K | 3.13K | 3.76K | 6.72K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.09B | 4.23B | 3.13B | 3.76B | 6.72B |
| EBIT | 9.68B | 6.90B | 6.72B | 7.46B | 8.53B |
| EBITDA | 15.16B | 12.33B | 11.65B | 11.89B | 12.46B |
| EPS Basic | 7.62 | 7.88 | 5.85 | 7.03 | 12.57 |
| Normalized Basic EPS | 7.69 | 4.06 | 4.34 | 4.74 | 6.33 |
| EPS Diluted | 7.55 | 7.81 | 5.81 | 7.00 | 12.49 |
| Normalized Diluted EPS | 7.62 | 4.03 | 4.31 | 4.71 | 6.29 |
| Average Basic Shares Outstanding | 2.15B | 2.15B | 2.14B | 2.14B | 2.14B |
| Average Diluted Shares Outstanding | 2.16B | 2.16B | 2.16B | 2.15B | 2.15B |
| Dividend Per Share | 9.00 | 8.88 | 8.76 | 8.64 | 8.52 |
| Payout Ratio | 118.14% | 112.70% | 150.06% | 122.96% | 67.83% |
